Emmanuelle Jouanguy - Infectious Diseases

Author Information

Emmanuelle Jouanguy is a researcher associated with the Laboratory of Human Genetics of Infectious Diseases at the Necker Branch of the Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-1163, located at the Necker Hospital for Sick Children in Paris, France. Her work is primarily focused on understanding the genetic basis of infectious diseases, contributing significantly to the field through her research on human genetics and immune responses.

Research Contributions

Emmanuelle Jouanguy has made substantial contributions to the field of infectious diseases, particularly in understanding the genetic determinants that influence disease susceptibility and severity. Her recent work includes studies on the role of type I interferons in COVID-19 and the genetic factors associated with severe viral diseases. Noteworthy publications include research on the impact of autoantibodies neutralizing type I interferons in COVID-19 fatalities, and the identification of a loss-of-function IFNAR1 allele linked to severe viral diseases among Polynesians. Her research is pivotal in advancing knowledge on the interplay between genetic factors and infectious disease outcomes.

Aliases

Emmanuelle Jouanguy is also known by the names E Jouanguy and E. Jouanguy. These aliases are used interchangeably in various publications and academic contexts.

Publication and Citation Metrics

Metric	Value
Citation Count	22,902
H-index	72
Paper Count	205

Publications:

Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions.

DOI: 10.1172/jci.insight.156021

Year: 2022

Type I interferons and SARS-CoV-2: from cells to organisms

DOI: 10.1016/j.coi.2022.01.003

Year: 2022

Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital

DOI: 10.1007/s10875-021-01203-3

Year: 2022

A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.

DOI: 10.1084/jem.20220028

Year: 2022

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

DOI: 10.1084/jem.20211381

Year: 2022

Recalcitrant Cutaneous Warts in a Family with Inherited ICOS Deficiency.

DOI: 10.1016/j.jid.2022.02.011

Year: 2022

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

DOI: 10.21203/rs.3.rs-1225906/v1

Year: 2022

In memoriam: Stephen J Seligman, MD

DOI: 10.1007/s10875-021-01204-2

Year: 2022

Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child

DOI: 10.1073/pnas.2114390118

Year: 2021

Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.

DOI: 10.1084/jem.20210566

Year: 2021

What is the Role of Centers for Disease Control and Prevention?

How can individuals protect themselves from HIV?

What Role Does Sanitization Play in Infection Control?

Where is Yellow Fever Prevalent?

What is Polymerase Chain Reaction (PCR)?

What is the Role of the FDA in Infectious Diseases?

How Does the CDC Respond to Emerging Infectious Diseases?

How is Pink Eye Diagnosed?

What is Toxicity?

What are the Phases of the Inflammatory Response?

Partnered Content Networks

Relevant Topics